Overview

Study of the Effect of Individualizing Daytrana Wear-times on Sleep in Children With ADHD

Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
0
Participant gender:
All
Summary
Methylphenidate may improve sleep in children with ADHD. By leaving Daytrana (methylphenidate) patch for a longer time then 9 hours, many children report short sleep latencies and better quality of sleep.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cox Health Systems
Treatments:
Methylphenidate
Criteria
Inclusion Criteria:

- ADHD without significant comorbidity

Exclusion Criteria:

- Cardiac disorder

- Hypertension

- Thyroid disease

- Glaucoma

- History of sudden death, motor tics and/or Tourette's syndrome

- Hypersensitivity to methylphenidate